Multimodal Respiratory Physiotherapy in Women Receiving Radiotherapy for Breast Cancer (RESPIRA-BC)

NCT07884968 — Not applicable, Completed, 22 participants, University of Alcala

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Multimodal Respiratory Physiotherapy Including Incentive Spirometry and Positive Expiratory Pressure for Women Treated for Breast Cancer With Radiotherapy: a Pilot Randomised Controlled Trial.

RegistryNCT07884968, acronym RESPIRA-BC
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, supportive care
Enrollment22 (Actual)
SponsorUniversity of Alcala (Other)
ConditionsBreast Neoplasms
InterventionsIncentive Spirometry (IS) and Positive Expiratory Pressure (PEP) Training, Individualised Exercise Programme (Aerobic and Resistance Training), Patient Education Programme (Other)
Datesstart 2022-03-01, primary completion 2023-12-01, completion 2024-12-01, first posted 2026-10-21, last updated 2026-10-21
Locations1 site in Spain

Related Papers Related Patents Related Grants Related Experts
All trials for Breast Neoplasms All trials of Incentive Spirometry (IS) and Positive Expiratory Pressure (PEP) Training All trials of Individualised Exercise Programme (Aerobic and Resistance Training)

-Summary

Radiotherapy is an important treatment for breast cancer, but it may affect lung function and physical ability, making everyday activities more difficult. Breathing exercises may help women recover after treatment, although more research is needed.

The main aim of this pilot study was to assess whether a four-week respiratory physiotherapy programme was practical and safe for women treated for breast cancer with radiotherapy. The study also explored its potential benefits for lung function, physical ability, physical activity, fatigue and quality of life.

Participants were randomly assigned to two groups. Both groups received patient education and an individualised exercise programme. In addition, one group performed breathing exercises at home using two devices: one to encourage deep breathing (incentive spirometry) and another to provide resistance when breathing out (positive expiratory pressure). The study compared both groups to explore whether adding these breathing exercises provided additional benefits.

Expand all sections  ·  Collapse all

+Detailed description

This single-centre, two-arm, parallel-group, assessor-blinded pilot randomised controlled trial was conducted at the Hospital Universitario Príncipe de Asturias in Alcalá de Henares, Spain. Physiotherapy interventions were delivered at the University of Alcalá.

Participants were allocated using a computer-generated randomisation sequence, with allocation concealment maintained through sequentially numbered, opaque, sealed envelopes. Outcome assessments were conducted by researchers who remained unaware of group allocation.

The physiotherapy intervention began three months after completion of radiotherapy and lasted four weeks. Participants attended four individual, face-to-face physiotherapy sessions, scheduled once weekly. The programme included patient education and individually prescribed aerobic and resistance exercise, performed independently at home or in community settings. Additional respiratory training was performed using incentive spirometry and positive expiratory pressure devices, following individual instruction and supervision.

Exercise and respiratory training were prescribed according to each participant's physical condition and tolerance. Physical activity was monitored using wrist-worn activity trackers, while adherence to the intervention was reviewed during the weekly sessions.

Assessments were conducted at five time points: before breast cancer surgery, after surgery, three months after radiotherapy (pre-intervention), four months after radiotherapy (post-intervention), and six months after radiotherapy (follow-up).

Feasibility was assessed through recruitment, retention, attendance, and adherence to the prescribed activities. Safety was evaluated by recording adverse events during the intervention period. Clinical outcomes were analysed exploratorily to estimate changes over time and between-group differences, accounting for age, body mass index, and the number of radiotherapy sessions.

+Arms and interventions

ArmTypeInterventionsDescription
Multimodal Respiratory Physiotherapy (IS + PEP)ExperimentalOther: Incentive Spirometry (IS) and Positive Expiratory Pressure (PEP) Training; Other: Individualised Exercise Programme (Aerobic and Resistance Training); Other: Patient Education ProgrammeParticipants received a four-week multimodal respiratory physiotherapy programme comprising patient education, individually prescribed aerobic and resistance exercise, and home-based respiratory training using incentive spirometry (IS) and positive expiratory pressure (PEP) devices.
Exercise and Patient EducationActive comparatorOther: Individualised Exercise Programme (Aerobic and Resistance Training); Other: Patient Education ProgrammeParticipants received a four-week programme comprising patient education and individually prescribed aerobic and resistance exercise.
  • Incentive Spirometry (IS) and Positive Expiratory Pressure (PEP) Training (Other): Participants completed a four-week home-based respiratory training programme combining incentive spirometry (IS) and positive expiratory pressure (PEP) using Voldyne 5000 and Threshold PEP devices, respectively. Training was performed for at least 30 minutes per day, five days per week, comprising 2-4 sets of 8-15 deep inspirations with a 3-5-second breath hold, followed by 8-15 breaths against expiratory resistance, with 2-3 minutes of rest between sets. Participants received initial supervised instruction, and training parameters were reviewed and individually adjusted during weekly physiotherapy sessions.
  • Individualised Exercise Programme (Aerobic and Resistance Training) (Other): Participants received a four-week individually prescribed exercise programme combining aerobic and resistance training. Aerobic exercise consisted of walking or cycling for at least 30 minutes per day, five days per week, at moderate-to-vigorous intensity (70-85% of age-predicted maximum heart rate). Resistance training targeted major muscle groups, comprising 2-4 sets of 8-12 repetitions, twice weekly, initially at 40-60% of one-repetition maximum. Exercises were performed independently at home or in community settings, with individual prescriptions reviewed during weekly physiotherapy sessions.
  • Patient Education Programme (Other): Participants received a four-week patient education programme addressing respiratory anatomy and physiology, potential respiratory consequences of breast cancer treatment, and the benefits of physical exercise for cardiorespiratory function and functional capacity. Education was delivered during weekly face-to-face physiotherapy sessions and supported by printed educational materials.

+Outcome measures

Primary outcomes

  • Recruitment Rate [During the recruitment period]: Proportion of eligible women who agreed to participate and were enrolled and randomised in the study, expressed as a percentage of all eligible women invited to participate.
  • Screening-to-Randomisation Yield [During the recruitment period]: Description Proportion of women randomised into the study relative to the total number of women assessed for eligibility, expressed as a percentage.
  • Retention Rate [From randomisation to the final follow-up assessment (six months after radiotherapy).]: Proportion of randomised participants who completed all study assessments, expressed as a percentage of the total number of randomised participants.
  • Attendance at Face-to-Face Physiotherapy Sessions [Throughout the four-week intervention period.]: Proportion of individual face-to-face physiotherapy sessions attended relative to the total number of scheduled sessions, expressed as a percentage.
  • Adherence to the Home-Based Exercise Programme [Throughout the four-week intervention period.]: Proportion of intervention weeks during which participants achieved the prescribed exercise target of at least 30 minutes per day, five days per week, expressed as a percentage.
  • Adherence to Respiratory Training [Throughout the four-week intervention period.]: Proportion of intervention weeks during which participants in the experimental group achieved the prescribed respiratory training target of at least 30 minutes per day, five days per week, expressed as a percentage.
  • Adverse Events Related to the Intervention (Safety) [Throughout the four-week intervention period]: Number and proportion of participants experiencing adverse events during the intervention period. Adverse events were recorded and classified according to their type, seriousness, and potential relationship to the study intervention.

Secondary outcomes

  • Forced Expiratory Volume in One Second (FEV1) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Forced expiratory volume in one second (FEV1) was assessed using spirometry and expressed as a percentage of the predicted value (% predicted).
  • Forced Vital Capacity (FVC) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Forced vital capacity (FVC) was assessed using spirometry and expressed as a percentage of the predicted value (% predicted).
  • Diffusing Capacity of the Lung for Carbon Monoxide (DLCOadj) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Lung diffusing capacity for carbon monoxide (DLCO), adjusted for haemoglobin concentration, was assessed using the single-breath diffusion test and expressed as a percentage of the predicted value (% predicted).
  • Alveolar Volume (VA) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Alveolar volume (VA) was assessed during the single-breath lung diffusion test and expressed as a percentage of the predicted value (% predicted).
  • Carbon Monoxide Transfer Coefficient (KCO) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Carbon monoxide transfer coefficient (KCO) was assessed using the single-breath lung diffusion test and expressed as a percentage of the predicted value (% predicted).
  • One-Minute Sit-to-Stand Test (1minSTS) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Functional capacity was assessed using the one-minute sit-to-stand test (1minSTS). The total number of complete sit-to-stand repetitions performed within one minute was recorded.
  • Six-Minute Walking Distance (6MWD) [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: Functional capacity was assessed using the six-minute walk test (6MWT). The total distance walked in six minutes was recorded in metres.
  • Self-reported physical activity and sedentary time [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: It was were assessed using the International Physical Activity Questionnaire-short form-IPAQ-sf and expressed as metabolic equivalent minutes per week (MET-min/week).
  • Fatigue [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: It was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-FS).
  • Health-Related Quality of Life [Before surgery (T0), after surgery (T1), at 3 months after radiotherapy/before intervention (T2), at 4 months after radiotherapy/after intervention (T3), and at 6 months after radiotherapy (T4). Randomisation occurred between T1 and T2]: It was assessed using the Functional Assessment of Cancer Therapy-Breast questionnaire

+Eligibility

Sex: Female, ages: 18 Years to any

Inclusion Criteria:

* Women with unilateral breast cancer.
* Scheduled to undergo breast cancer surgery.
* Adjuvant radiotherapy planned as part of oncological treatment.

Exclusion Criteria:

* Bilateral breast cancer.
* Metastatic breast cancer.
* Severe cardiorespiratory conditions limiting exercise participation.
* Severe neurological conditions limiting exercise participation.
* Severe musculoskeletal conditions limiting exercise participation.
* Cognitive impairment affecting comprehension of the intervention.
* Any other condition preventing completion of the study assessments or intervention

+Locations (1)

FacilityCityCountryStatus
Faculty of Nursing and Physiotherapy, University of AlcaláAlcalá de Henares, MadridSpain